Drugs / Everolimus with reduced TAC
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03596970 Comparator | Sep 2015 → Dec 2020 | — | Novartis Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Everolimus with reduced TAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03596970 ↗ |